Adaptive Biotechnologies
ADPT
#4738
Rank
C$2.65 B
Marketcap
C$17.24
Share price
-11.10%
Change (1 day)
46.59%
Change (1 year)

Revenue for Adaptive Biotechnologies (ADPT)

Revenue in 2025 (TTM): C$0.38 Billion

According to Adaptive Biotechnologies 's latest financial reports the company's current revenue (TTM ) is C$0.38 Billion. an increase over the revenue in the year 2024 that were of C$0.25 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adaptive Biotechnologies from 2018 to 2025

Annual revenue

Year Revenue Change
2025 C$0.37 B47.71%
2024 C$0.25 B13.71%
2023 C$0.22 B-10.18%
2022 C$0.25 B27.83%
2021 C$0.19 B56.8%
2020 C$0.12 B12.9%
2019 C$0.11 B46.53%
2018 C$75.82 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HCA Healthcare
HCA
C$105.02 B 27,194.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
C$1.39 B 262.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
C$17.56 B 4,465.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
C$7.57 B 1,868.70%๐Ÿ‡บ๐Ÿ‡ธ USA